UNIverse - Public Research Portal
Project cover

Development of brain-penetrant MNK inhibitors

Research Project
 | 
01.03.2023
 - 30.08.2024

MAP-kinase interacting kinases (MNKs) are a novel target for the treatment of autism spectrum disorders. We aim to develop a brain-penetrant, small molecule inhibitor that selectively targets MNKs and alleviates the core symptoms of autism.

Funding

Development of brain-penetrant MNK inhibitors

Innosuisse Projekt (GrantsTool), 03.2023-08.2024 (18)
PI : Genç, Özgür,Lill, Markus A.,Scheiffele, Peter.

Members (3)

MALE avatar

Özgür Genç

Principal Investigator
Profile Photo

Markus A. Lill

Principal Investigator
Profile Photo

Peter Scheiffele

Principal Investigator